Related content

A phase II trial with monoclonal antibody WX-G250 in advanced renal cell carcinoma

By Bleumer I.   Beck J.   Hofmann R.   Kruit W.   Warnaar S.   Mala C.   Ullrich S.   Huber C.   Debruyne F.M.J.   Oosterwijk E.   Mulders P.F.A.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 112-112

Elsevier

Access to resources Recommend Favorite

Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen

By Chan T.Y.   Mikolajczyk S.D.   Lecksell K.   Shue M.J.   Rittenhouse H.G.   Partin A.W.   Epstein J.I.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 177-181

Elsevier

Access to resources Recommend Favorite

Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis

By Giménez-Bachs José M.   Salinas-Sánchez Antonio S.   Serrano-Oviedo Leticia   Nam-Cha Syong H.   Rubio-Del Campo Antonio   Sánchez-Prieto Ricardo  

Scandinavian Journal of Urology and Nephrology, Vol. 46, Iss. 5, 2012-10 ,pp. : 358-364

Informa Healthcare

Access to resources Recommend Favorite

Enhanced Dendritic Cell Antigen Presentation in RNA-Based Immunotherapy

By Kalady M.F.   Onaitis M.W.   Padilla K.M.   Emani S.   Tyler D.S.   Pruitt S.K.  

Journal of Surgical Research, Vol. 105, Iss. 1, 2002-06 ,pp. : 17-24

Academic Press

Access to resources Recommend Favorite

Informed consent for prostate-specific antigen-based screening

By Brawley O.W.  

Urology, Vol. 61, Iss. 1, 2003-01 ,pp. : 10-12

Elsevier

Access to resources Recommend Favorite